down arrow

Tyra Biosciences, Inc.

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: US90240B1061
USD
22.11
1.19 (5.69%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

21.4322.13

52 Week

6.4222.82
Valuation
Technical
Day's Volume

CASH

916.9 k

Shareholding (Mar 2025)

FII

10.96%

Held by 47 FIIs

DII

38.92%

Held by 20 DIIs

Promoter

36.97%

How big is Tyra Biosciences, Inc.?

22-Jun-2025

As of Jun 18, Tyra Biosciences, Inc. has a market capitalization of 509.98 million and reported net sales of 0.00 million with a net profit of -96.44 million for the latest four quarters. The balance sheet shows shareholder's funds of 343.15 million and total assets of 365.10 million.

As of Jun 18, Tyra Biosciences, Inc. has a market capitalization of 509.98 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, with a net profit of -96.44 million during the same period.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 343.15 million and total assets of 365.10 million.

Read More

What does Tyra Biosciences, Inc. do?

22-Jun-2025

Tyra Biosciences, Inc. is a micro-cap company in the miscellaneous industry, currently reporting a net profit loss of $28 million and a market cap of $509.98 million. Key financial metrics include a negative P/E ratio, a 0.00% dividend yield, and a debt-to-equity ratio of -0.98.

Overview: <BR>Tyra Biosciences, Inc. operates in the miscellaneous industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -28 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 509.98 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.98 <BR>Return on Equity: -29.81% <BR>Price to Book: 1.58<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is Tyra Biosciences, Inc. technically bullish or bearish?

20-Sep-2025

As of June 2, 2025, Tyra Biosciences, Inc. has a mildly bearish trend, with daily moving averages indicating this stance, while it has outperformed the S&P 500 recently but significantly underperformed year-to-date and over the past year.

As of 2 June 2025, the technical trend for Tyra Biosciences, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating a mildly bearish position, while the weekly MACD and Bollinger Bands show bullish signals. However, the monthly MACD and KST are bearish, contributing to the overall mildly bearish outlook. <BR><BR>In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 2.57% and 18.32% respectively, but it has significantly underperformed on a year-to-date and one-year basis, with returns of -7.99% and -44.87% compared to the S&P 500's 12.22% and 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 646 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.98

stock-summary
Return on Equity

-35.03%

stock-summary
Price to Book

2.14

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-28 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
79.46%
0%
79.46%
6 Months
129.12%
0%
129.12%
1 Year
44.89%
0%
44.89%
2 Years
90.44%
0%
90.44%
3 Years
226.11%
0%
226.11%
4 Years
24.7%
0%
24.7%
5 Years
0%
0%
0.0%

Tyra Biosciences, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Tyra Biosciences, Inc. technically bullish or bearish?

As of 2 June 2025, the technical trend for Tyra Biosciences, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating a mildly bearish position, while the weekly MACD and Bollinger Bands show bullish signals. However, the monthly MACD and KST are bearish, contributing to the overall mildly bearish outlook. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 2.57% and 18.32% respectively, but it has significantly underperformed on a year-to-date and one-year basis, with returns of -7.99% and -44.87% compared to the S&P 500's 12.22% and 17.14%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-264.66%
EBIT to Interest (avg)
-86.70
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.98
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.73
EV to EBIT
-2.13
EV to EBITDA
-2.14
EV to Capital Employed
48.34
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2266.89%
ROE (Latest)
-29.81%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 28 Schemes (13.15%)

Foreign Institutions

Held by 47 Foreign Institutions (10.96%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -50.27% vs -40.60% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-31.30",
          "val2": "-23.40",
          "chgp": "-33.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-28.10",
          "val2": "-18.70",
          "chgp": "-50.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -25.18% vs -24.95% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-103.70",
          "val2": "-79.60",
          "chgp": "-30.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-86.50",
          "val2": "-69.10",
          "chgp": "-25.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-31.30
-23.40
-33.76%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-28.10
-18.70
-50.27%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -50.27% vs -40.60% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-103.70
-79.60
-30.28%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-86.50
-69.10
-25.18%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -25.18% vs -24.95% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Tyra Biosciences, Inc. stock-summary
stock-summary
Tyra Biosciences, Inc.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."